Awakening to sleep disorders in Europe: Survey on education, knowledge and treatment competence of European residents and neurologists

Rakuša, Martin; Siemiński, Mariusz; Rakusa, Sofia; Falup‐Pecurariu, Cristian; Fronczek, Rolf; Hidalgo, Hildegard; Muntean, Maria‐Lucia; Pijpers, Angelique; Cock, Valérie Cochen De; Pizza, Fabio; Schmidt, Markus H.; Schreier, David; Baldin, Elisa; Bassetti, Claudio; Kallweit, Ulf

doi:10.1111/ene.14954

Cited by 8 publications

(5 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, the sample size was sufficiently large to give the data substantial weight. We must also acknowledge the limitations of the study, which are similar to other survey-based studies (Moro et al, 2020;Rakusa et al, 2021). First, the dropout rate might be considered high given that only 549 individuals were included in the analysis from almost 25,000 screened respondents.…”

Section: Discussionmentioning

confidence: 94%

Diagnosis, management and impact on patients' lives of cancer‐related neuropathic pain (CRNP): A European survey

Dupoiron

Brill

Eeltink

et al. 2022

European J Cancer Care

View full text Add to dashboard Cite

Objective This study assessed the impact of cancer‐related neuropathic pain (CRNP) on patients and the importance of the patient–healthcare professional (HCP) relationship in diagnosis and management. Methods A quantitative online survey was conducted involving adult patients from 13 European countries who had been diagnosed with treatable cancer and experienced symptoms of peripheral neuropathy. Results Of 24,733 screened respondents, 549 eligible persons met the inclusion criteria and completed the questionnaire. Among individuals still experiencing pain, 75% rated it as ‘severe’ or ‘moderate’. In addition, 61% reported a negative impact on day‐to‐day activities, and 30% said they had stopped working as a result. A third of respondents had received no diagnosis of CRNP despite reporting painful symptoms to an HCP. HCPs spending enough time discussing pain and understanding the impact on patients' lives were each associated with an increased likelihood of a formal CRNP diagnosis. Compared with individuals currently in active cancer treatment, cancer survivors were less likely to have a diagnosis of CRNP or regular pain conversations with HCPs. Conclusion CRNP remains under‐recognised despite its substantial impact on patients' lives. Clinical practice may be improved by strengthening patient–HCP relationships around pain discussions and increasing the focus on pain management among cancer survivors.

show abstract

Section: Discussionmentioning

confidence: 94%

Diagnosis, management and impact on patients' lives of cancer‐related neuropathic pain (CRNP): A European survey

Dupoiron

Brill

Eeltink

et al. 2022

European J Cancer Care

View full text Add to dashboard Cite

show abstract

“…The first 3 years are devoted to acquiring the skills in general neurology, whilst the remaining two include elective rotations in neurophysiology and different subspecialties and the option of rotations in research. In this revised version of the ETRN emerging subspecialties (e.g., sleep medicine, neurorehabilitation, palliative and preventive neurology/brain health [24,27]) and novel approaches (e.g., neuroinformatics, teleneurology) are better represented. Similar teams operate in the Netherlands and Belgium [30].…”

Section: Discussionmentioning

confidence: 99%

“…For example, in 2012 there were 25 neurological subspecialties recognized in the United States [22]. Thirdly, different surveys have shown shortcomings in current residency programmes concerning diagnostic and therapeutic procedures, practical skills and specialized contents such as sleep medicine [23,24]. Fourthly, there is a growing need for international standardization of teaching due to the increased mobility of European students, residents and specialists.…”

Section: The Ne W Europe An P Os Tg R Aduate (Re S Iden C Y ) Prog R ...mentioning

confidence: 99%

The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective

Bassetti

Soffietti

Vodušek

et al. 2023

Euro J of Neurology

Self Cite

View full text Add to dashboard Cite

Background and purposeNeurology residency programmes, which were first established at the beginning of the 20th century, have become mandatory all over Europe in the last 40–50 years. The first European Training Requirements in Neurology (ETRN) were published in 2005 and first updated in 2016. This paper reports the most recent revisions of the ETRN.MethodsMembers of the EAN board performed an in depth revision of the ETNR 2016‐version, which was reviewed by members of the European Board and Section of Neurology of the UEMS, the Education and Scientific Panels, the Resident and Research Fellow Section and the Board of the EAN, as well as the presidents of the 47 European National Societies.ResultsThe new (2022) ETRN suggest a 5‐year training subdivided in three phases: a first phase (2 years) of general neurology training, a second phase (2 years) of training in neurophysiology/neurological subspecialties and a third phase (1 year) to expand clinical training (e.g., in other neurodisciplines) or for research (path for clinical neuroscientist). The necessary theoretical and clinical competences as well as learning objectives in diagnostic tests have been updated, are newly organized in four levels and include 19 neurological subspecialties. Finally, the new ETRN require, in addition to a programme director, a team of clinician‐educators who regularly review the resident's progress.The 2022 update of the ETRN reflects emerging requirements for the practice of neurology and contributes to the international standardization of training necessary for the increasing needs of residents and specialists across Europe.

show abstract

“…Sleep-wake-circadian changes (SWCD) have a bidirectional relationship with neurological and neuropsychiatric diseases. They can act as driving forces or modulators but also emerge as early symptoms [24][25][26]. To monitor sleep over extended periods, we want to test and validate a system that allows for unobtrusive, easy-to-use, and long-term in-home measuring of sleep and related relevant parameters.…”

Section: Monitoring Sleep At-homementioning

confidence: 99%

NeuroTec Sitem-Insel Bern: Closing the Last Mile in Neurology

Schindler

Nef

Baud

et al. 2021

CTN

Self Cite

View full text Add to dashboard Cite

Neurology is focused on a model where patients receive their care through repeated visits to clinics and doctor’s offices. Diagnostic tests often require expensive and specialized equipment that are only available in clinics. However, this current model has significant drawbacks. First, diagnostic tests, such as daytime EEG and sleep studies, occur under artificial conditions in the clinic, which may mask or wrongly emphasize clinically important features. Second, early detection and high-quality management of chronic neurological disorders require repeat measurements to accurately capture the dynamics of the disease process, which is impractical to execute in the clinic for economical and logistical reasons. Third, clinic visits remain inaccessible to many patients due to geographical and economical circumstances. Fourth, global disruptions to daily life, such as the one caused by COVID-19, can seriously harm patients if access to in-person clinical visits for diagnostic and treatment purposes is throttled. Thus, translating diagnostic and treatment procedures to patients’ homes will convey multiple substantial benefits and has the potential to substantially improve clinical outcomes while reducing cost. NeuroTec was founded to accelerate the re-imagining of neurology and to promote the convergence of technological, scientific, medical and societal processes. The goal is to identify and validate new digital biomarkers that can close the last mile in neurology by enabling the translation of personalized diagnostics and therapeutic interventions from the clinic to the patient’s home.

show abstract

Awakening to sleep disorders in Europe: Survey on education, knowledge and treatment competence of European residents and neurologists

Cited by 8 publications

References 25 publications

Diagnosis, management and impact on patients' lives of cancer‐related neuropathic pain (CRNP): A European survey

Diagnosis, management and impact on patients' lives of cancer‐related neuropathic pain (CRNP): A European survey

The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective

NeuroTec Sitem-Insel Bern: Closing the Last Mile in Neurology

Contact Info

Product

Resources

About